See more : Terramin Australia Limited (TZN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Gujarat Terce Laboratories Limited (GUJTERC.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gujarat Terce Laboratories Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Albina Community Bancorp (ACBCQ) Income Statement Analysis – Financial Results
- Story-I Limited (SRY.AX) Income Statement Analysis – Financial Results
- Liberty Gold Corp. (0V46.L) Income Statement Analysis – Financial Results
- Power Grid Corporation of India Limited (POWERGRID.BO) Income Statement Analysis – Financial Results
- BlackBerry Limited (BB) Income Statement Analysis – Financial Results
Gujarat Terce Laboratories Limited (GUJTERC.BO)
About Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Ltd. engages in the manufacture and sale of pharmaceutical products. Its product portfolio encompasses therapeutics relating to anti fungal, anti malarial, antibiotic, ayurvedic, cardiovascular therapy, gastrointestinal therapy, gynecological, miscellaneous, nutraceutical, pain therapy, and respiratory system. The company was founded by Mr. N.P. Prajapati on March 28, 1985 and is headquartered in in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 479.75M | 467.83M | 401.34M | 251.78M | 375.44M | 310.31M | 290.14M | 252.88M | 249.94M | 264.81M | 288.46M | 790.16M |
| Cost of Revenue | 338.34M | 405.08M | 316.60M | 231.94M | 291.89M | 253.75M | 236.22M | 209.25M | 205.98M | 103.48M | 139.73M | 655.82M |
| Gross Profit | 141.41M | 62.75M | 84.74M | 19.84M | 83.55M | 56.55M | 53.92M | 43.63M | 43.96M | 161.33M | 148.73M | 134.34M |
| Gross Profit Ratio | 29.48% | 13.41% | 21.11% | 7.88% | 22.25% | 18.23% | 18.59% | 17.25% | 17.59% | 60.92% | 51.56% | 17.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.75M | 7.43M | 7.74M | 7.29M | 9.10M | 34.42M | 31.47M | 27.56M | 27.65M | 88.28M | 3.19M | 1.75M |
| Selling & Marketing | 48.06M | 35.08M | 29.90M | 16.53M | 42.10M | 17.59M | 19.33M | 12.77M | 13.13M | 30.93M | 44.96M | 35.34M |
| SG&A | 132.42M | 82.65M | 75.75M | 47.16M | 76.34M | 52.02M | 50.80M | 40.33M | 40.78M | 119.21M | 122.23M | 103.64M |
| Other Expenses | 0.00 | -856.00K | -457.00K | -132.49K | -2.64M | -1.69M | -1.65M | -4.30M | -3.45M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 132.42M | 83.51M | 76.20M | 47.29M | 78.98M | 53.71M | 52.45M | 44.63M | 44.23M | 153.39M | 142.35M | 127.97M |
| Cost & Expenses | 470.37M | 488.59M | 392.80M | 279.23M | 370.87M | 307.46M | 288.67M | 253.88M | 250.20M | 256.87M | 282.08M | 783.79M |
| Interest Income | 3.03M | 3.55M | 2.88M | 3.02M | 2.81M | 2.49M | 427.40K | 1.39M | 1.66M | 3.63M | 2.97M | 3.65M |
| Interest Expense | 6.76M | 7.21M | 4.01M | 3.89M | 2.92M | 2.54M | 2.26M | 3.11M | 3.51M | 4.04M | 3.83M | 0.00 |
| Depreciation & Amortization | 3.68M | 3.65M | 2.76M | 1.76M | 2.42M | 2.11M | 1.85M | 1.89M | 1.90M | 1.58M | 3.34M | 3.17M |
| EBITDA | 15.88M | -18.08M | 14.23M | -19.66M | 9.69M | 8.11M | 7.36M | 888.29K | 3.52M | 8.63M | 10.83M | 10.21M |
| EBITDA Ratio | 3.31% | -3.66% | 2.82% | -10.20% | 1.86% | 1.60% | 1.15% | 0.35% | 0.65% | 3.46% | 3.35% | 1.24% |
| Operating Income | 9.27M | -20.76M | 8.54M | -27.45M | 4.57M | 2.85M | 1.47M | -1.00M | -264.04K | 7.59M | 6.32M | 6.63M |
| Operating Income Ratio | 1.93% | -4.44% | 2.13% | -10.90% | 1.22% | 0.92% | 0.51% | -0.40% | -0.11% | 2.87% | 2.19% | 0.84% |
| Total Other Income/Expenses | -3.83M | -8.18M | -950.00K | 2.14M | -210.78K | 691.01K | 1.87M | 1.22M | -1.89M | -3.27M | -2.91M | -3.92M |
| Income Before Tax | 5.44M | -28.94M | 7.47M | -25.32M | 4.36M | 3.46M | 3.25M | 215.66K | -2.15M | 4.31M | 3.41M | 2.72M |
| Income Before Tax Ratio | 1.13% | -6.19% | 1.86% | -10.05% | 1.16% | 1.11% | 1.12% | 0.09% | -0.86% | 1.63% | 1.18% | 0.34% |
| Income Tax Expense | 3.01M | -12.22M | -1.26M | -113.61K | 1.60M | -868.01K | 545.02K | 363.76K | 4.59M | 3.40M | 1.01M | 821.96K |
| Net Income | 2.43M | -16.72M | 8.72M | -25.20M | 2.76M | 4.33M | 2.71M | -148.10K | -6.74M | 913.35K | 2.41M | 1.89M |
| Net Income Ratio | 0.51% | -3.57% | 2.17% | -10.01% | 0.74% | 1.39% | 0.93% | -0.06% | -2.70% | 0.34% | 0.83% | 0.24% |
| EPS | 0.33 | -2.25 | 1.18 | -3.40 | 0.37 | 0.58 | 0.36 | -0.02 | -0.91 | 0.12 | 0.32 | 0.26 |
| EPS Diluted | 0.33 | -2.25 | 1.18 | -3.40 | 0.37 | 0.58 | 0.36 | -0.02 | -0.91 | 0.12 | 0.32 | 0.26 |
| Weighted Avg Shares Out | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.43M | 7.42M | 7.43M |
| Weighted Avg Shares Out (Dil) | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M | 7.43M | 7.42M | 7.42M |
Source: https://incomestatements.info
Category: Stock Reports